newsfilter
← Latest News
GlobeNewswire·

Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today annou